Roche Vorzug Logo

Roche Vorzug

🇨🇭
ROP
CH1499059983

Roche Vorzug is a leading Swiss company in the pharmaceutical and diagnostics sector, headquartered in Basel. The company focuses on developing innovative medicines and diagnostic solutions. Through personalized healthcare, Roche improves the treatment of complex diseases on a global scale.

Next Quarterly Earnings

Thursday, October 22, 2026
CW 43
Pre-Market
In 9 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until October 22, 2026

Stock Price

Earnings preview

Roche Vorzug (ROP) is scheduled to release its Q3 2026 financial results on October 22, 2026, before the market open. Analysts estimate the company's revenue will reach 15553 million CHF. In the last reported quarter (Q2 2026), Roche Vorzug reported an EPS of 10.85 CHF, beating the analyst estimate of 10.33 CHF by 5.0%.

Generated automatically from our data — as of 10/08/2026

Recap: the latest results

Roche Vorzug (ROP) reported its Q2 2026 financial results on July 23, 2026, before the market opened. The company reported earnings per share (EPS) of 10.85 CHF, beating the analyst estimate of 10.33 CHF by 5.0%. Revenue for the quarter reached 15,642 million CHF. Following the release, the stock price rose by 5.14%.

Generated automatically from our data — as of 07/29/2026 Read the article →

Frequently asked questions

When will Roche Vorzug report its next quarterly earnings?

Roche Vorzug is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Roche Vorzug last report quarterly earnings?

Roche Vorzug last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 10.85 CHF.

How does Roche Vorzug stock react to earnings?

Across its last 3 earnings reports, Roche Vorzug stock moved by ±3.8% on average the following day. The largest reaction was +5.1% on 07/23/2026; 3 of 3 reactions were positive.

Does Roche Vorzug pay a dividend?

For fiscal year 2025, Roche Vorzug paid a dividend of 9.80 CHF per share.

How do I add the Roche Vorzug earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:—
Actual:—
Q2 2026
Beat
Estimate:CHF 10.33
Actual:CHF 10.85
Difference:+CHF 0.52
Price reaction (1 day):+5.1 %
Price reaction (7 days):+6.3 %
Q1 2026
Estimate:—
Actual:—
Price reaction (1 day):+3.8 %
Price reaction (7 days):+1.7 %
Q4 2025
Estimate:—
Actual:CHF 8.38
Price reaction (1 day):+2.6 %
Price reaction (7 days):+6.0 %

Earnings statistics

Stock reaction to earnings

±3.8%
Avg. next-day move
+5.1%
Largest move (07/23/2026)
100%
Share of positive reactions
±4.7%
Avg. move after 7 days

Basis: price reactions to the last 3 report dates (close to close).

Past price reactions are not a reliable indicator of future performance.

Dividend history

9.80 CHF
Last dividend (FY 2025)
5
Fiscal years covered
Fiscal yearDividend per shareEx-datePayment date
2025 9.80 CHF3/12/20263/16/2026
2024 9.70 CHF––
2023 9.60 CHF––
2022 9.50 CHF––
2021 9.30 CHF––

Source: Roche Vorzug investor relations, 5 fiscal years.

Past dividends are no guarantee of future payouts.

Company Information

Name
Roche Vorzug
Ticker Symbol
ROP
ISIN
CH1499059983
Country
🇨🇭
Switzerland
Sector
More Financial Information